Skip to main content
. 2023 Jul 17;14:1167261. doi: 10.3389/fneur.2023.1167261

Table 2.

Participants` characteristics and functional outcomes at baseline.

Variables EXP group (n = 17) CON group (n = 16) p
Sex (Male/Female)a 14/3 15/1 0.316
Age (years) 48.7 ± 14.8 43.1 ± 16.2 0.304
BMI (kg/m2) 25.3 ± 1.7 25.1 ± 3.1 0.796
Type of stroke (infarction/hemorrhage) 6/11 8/8 0.393
Time since stroke (months) 16.2 ± 20.3 14 ± 10.2 0.695
hemiplegia side (Left/Right)a 6/11 8/8 0.393
Brunnstrom stages of LE (3/4/5/6)a 3/7/5/2 4/9/1/2 0.387
AFO for daily use (Yes/No)a 2/15 4/12 0.352
Cane for daily use (Yes/No)a 7/10 9/7 0.387
AFO use during tests (Yes/No)a 0/17 1/15 0.295
Cane use during tests (Yes/No)a 0/17 0/16
Gait velocity-normal (m/s) 0.35 ± 0.16 0.32 ± 0.14 0.571
Gait velocity-fast (m/s) 0.43 ± 0.18 0.4 ± 0.2 0.645
CST-Forward (0/1/2/3)a 3/0/3/11 5/0/1/10 0.468
CST-Backward (0/1/2/3)a 4/0/2/11 6/0/2/8 0.656
TUG_normal (s) 37.5 ± 15.4 41.1 ± 11.3 0.444
TUG_fast (s) 34.2 ± 16 35.9 ± 12.7 0.745
5-STS (s) 28.6 ± 12.6 30.8 ± 11.4 0.608
ABC score 66.5 ± 24.8 58.6 ± 23.3 0.352

p, between-group difference examined by the independent t-test or Pearson χ2 test. BMI, Body mass index; LE, lower extremity; CST, compensatory stepping test; TUG, timed up-and-go test; STS, sit-to-stand test; ABC, the activities-specific balance confidence scale.

a

Variables marked with “a” were analyzed by Pearson χ2, otherwise by the independent t-test.